Healthcare Dive: Aetna drops prices for HIV and AIDS drugs

Healthcare Dive: Aetna drops prices for HIV and AIDS drugs

By Heather Caspi

Dive Brief:

  • Aetna has confirmed that beginning June 1, it is moving HIV drugs down from its priciest category of cost sharing, which required members to pay up to half the cost of these expensive drugs, running some members as much as $1,000 per month.
  • Following allegations of discrimination from advocates, Aetna is putting the drugs in a category that will run patients between $5 and $100 after their deductibles are met.
  • Coventry has announced a similar move, and Humana is reportedly “in the process of developing options to address the high cost of certain specialty drugs” though it hasn’t specified details. Read the full article here. »

Related Content

For almost 50 years, the National Health Law Program has fought to expand access to quality health care to low-income individuals and underserved communities. Today we are pleased to launch a newly designed website for our future work to make health care a reality for all people. Please take time to peruse our new site, and sign up for our email updates to learn about us, watch the work we do, and become engaged.

Continue to site